Back to Search

GINGER JUSTICE, MD

MD

Trauma Surgery Physician

NPI: 1629230313IndividualAccepts Medicare

Specialties, Licenses & Credentials

Surgery Physician

Surgery

Code: 208600000X

003072(GA)32510(AL)
Surgical Critical Care Physician

Surgery — Surgical Critical Care

Code: 2086S0102X

MD459679(PA)
Trauma Surgery PhysicianPrimary

Surgery — Trauma Surgery

Code: 2086S0127X

74495(GA)

CMS Specialties

PrimaryGENERAL SURGERY

Education

MEDICAL COLLEGE OF GEORGIA SCHOOL OF MEDICINE

Class of 2008

Research & Publications (10)

A randomized, multicenter study of subcutaneous and intravenous darbepoetin alfa for the treatment of chemotherapy-induced anemia.
PMID 15860486·Ann Oncol·2005
3-trial
Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma.
PMID 19245430·Br J Haematol·2009
3-trial
Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
PMID 18606983·J Clin Oncol·2008
3-trial
A randomized, open-label, multicenter trial of immediate versus delayed intervention with darbepoetin alfa for chemotherapy-induced anemia.
PMID 17962619·Oncologist·2007
4-observational
Capecitabine plus 3-weekly irinotecan (XELIRI regimen) as first-line chemotherapy for metastatic colorectal cancer: phase II trial results.
PMID 17762434·Am J Clin Oncol·2007
3-trial
Randomized comparison of epoetin alfa (40,000 U weekly) and darbepoetin alfa (200 microg every 2 weeks) in anemic patients with cancer receiving chemotherapy.
PMID 16177289·Oncologist·2005
4-observational
A randomized, active-control, pilot trial of front-loaded dosing regimens of darbepoetin-alfa for the treatment of patients with anemia during chemotherapy for malignant disease.
PMID 12599240·Cancer·2003
3-trial
Darbepoetin alfa given every 1 or 2 weeks alleviates anaemia associated with cancer chemotherapy.
PMID 12177793·Br J Cancer·2002
3-trial
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma.
PMID 11398876·Ann Oncol·2001
3-trial
A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy.
PMID 11308270·Br J Cancer·2001
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
503 N 21ST ST
CAMP HILL, PA 17011

Locations (2)

Practice Location

503 N 21ST ST, CAMP HILL, PA
(717) 763-2100

Practice Location

55 WHITCHER ST NE STE 130, MARIETTA, GA
(770) 428-0462

Quick Facts

NPI
1629230313
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
4
Locations
2
Years in Practice
18
Publications
10

Are you this provider?

Claim Your Profile